Alivus Life Sciences Ltd.

The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 5886.16 millions.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 1114.83  millions as against Rs. 1354.50 millions reported during the corresponding quarter ended.A decline of 1649.78 millions was observed in the OP in the quarter ended June 2024 from 1950.12 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202406	202306	% Var	202406	202306	% Var	202403	202303	% Var
Sales	5886.16	5784.50	1.76	5886.16	5784.50	1.76	22832.14	21612.20	5.64
Other Income	54.93	18.51	196.76	54.93	18.51	196.76	120.42	289.57	-58.41
PBIDT	1649.78	1950.12	-15.40	1649.78	1950.12	-15.40	6862.88	6712.50	2.24
Interest	3.53	3.96	-10.86	3.53	3.96	-10.86	15.46	5.47	182.63
PBDT	1646.25	1946.16	-15.41	1646.25	1946.16	-15.41	6847.42	6707.03	2.09
Depreciation	143.87	126.12	14.07	143.87	126.12	14.07	534.52	420.94	26.98
PBT	1502.38	1820.04	-17.45	1502.38	1820.04	-17.45	6312.90	6286.09	0.43
TAX	387.55	465.54	-16.75	387.55	465.54	-16.75	1604.02	1616.48	-0.77
Deferred Tax	12.38	29.55	-58.10	12.38	29.55	-58.10	81.88	110.37	-25.81
PAT	1114.83	1354.50	-17.69	1114.83	1354.50	-17.69	4708.88	4669.61	0.84
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	28.03	33.71	-16.86	28.03	33.71	-16.86	30.06	31.06	-3.22